Advertisement

Topics

Chronic Obstructive Pulmonary Disease COPD Pipeline Review, H2 2017 [Report Updated: 31102017] Prices from USD $2000

01:02 EST 9 Nov 2017 | BioPortfolio Reports

Chronic Obstructive Pulmonary Disease COPD Pipeline Review, H2 2017


Summary


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Obstructive Pulmonary Disease COPD Pipeline Review, H2 2017, provides an overview of the Chronic Obstructive Pulmonary Disease COPD Respiratory pipeline landscape.


Chronic obstructive pulmonary disease COPD is a group of lung diseases. It is characterized by inability to completely breathe out air from the lungs leading to shortness of breath. The airflow to the lungs is further blocked. Other symptoms include cough, fatigue and chest pain. The disease tends to worsen over the time hence increasing the complications. The risk factors involved in causing COPD include smoking as the primary reason. Exposure to chemicals and air pollution also contribute in the development of COPD.


Report Highlights


Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Chronic Obstructive Pulmonary Disease COPD Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Chronic Obstructive Pulmonary Disease COPD Respiratory, complete with analysis by stage of development, drug target, mechanism of action MoA, route of administration RoA and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.


The Chronic Obstructive Pulmonary Disease COPD Respiratory pipeline guide also reviews of key players involved in therapeutic development for Chronic Obstructive Pulmonary Disease COPD and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in PreRegistration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 6, 1, 13, 37, 23, 84, 23 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 9 and 1 molecules, respectively.


Chronic Obstructive Pulmonary Disease COPD Respiratory pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.


Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.


Scope


The pipeline guide provides a snapshot of the global therapeutic landscape of Chronic Obstructive Pulmonary Disease COPD Respiratory.

The pipeline guide reviews pipeline therapeutics for Chronic Obstructive Pulmonary Disease COPD Respiratory by companies and universities/research institutes based on information derived from company and industryspecific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from preregistration till discovery and undisclosed stages.

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, RD brief, MoA other developmental activities.

The pipeline guide reviews key companies involved in Chronic Obstructive Pulmonary Disease COPD Respiratory therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Chronic Obstructive Pulmonary Disease COPD Respiratory therapeutics based on mechanism of action MoA, drug target, route of administration RoA and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

The pipeline guide reviews latest news related to pipeline therapeutics for Chronic Obstructive Pulmonary Disease COPD Respiratory


Reasons to buy


Procure strategically important competitor information, analysis, and insights to formulate effective RD strategies.

Recognize emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage.

Find and recognize significant and varied types of therapeutics under development for Chronic Obstructive Pulmonary Disease COPD Respiratory.

Classify potential new clients or partners in the target demographic.

Develop tactical initiatives by understanding the focus areas of leading companies.

Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

Formulate corrective measures for pipeline projects by understanding Chronic Obstructive Pulmonary Disease COPD Respiratory pipeline depth and focus of Indication therapeutics.

Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the knowhow what drove them from pipeline.

Original Article: Chronic Obstructive Pulmonary Disease COPD Pipeline Review, H2 2017 [Report Updated: 31102017] Prices from USD $2000

NEXT ARTICLE

More From BioPortfolio on "Chronic Obstructive Pulmonary Disease COPD Pipeline Review, H2 2017 [Report Updated: 31102017] Prices from USD $2000"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

COPD (chronic obstructive pulmonary disease)
COPD (chronic obstructive pulmonary disease) is used for a number of conditions including chronic bronchitis and emphysema, which all  lead to the airways in the lungs becoming damaged and thus narrower,  making inhalation and exhalation harder...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...